Clinical Trial: A Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Double-blind, Placebo-controlled, Crossover Study, Followed by Open-label Study of KPS-0373 in Patients With SCD

Brief Summary: To evaluate the efficacy and safety of KPS-0373 in patients with SCD.

Detailed Summary:
Sponsor: Kissei Pharmaceutical Co., Ltd.

Current Primary Outcome:

  • Scale for Assessment and Rating of Ataxia (SARA) [ Time Frame: 4 weeks + 12 weeks ]
  • Upper and lower extremity function [ Time Frame: 4 weeks + 12 weeks ]


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Kissei Pharmaceutical Co., Ltd.

Dates:
Date Received: October 27, 2009
Date Started:
Date Completion:
Last Updated: September 27, 2010
Last Verified: September 2010